“Nice to meet you” NUTRIM PhD Julien Luyten
Beating the odds: Julien Luyten’ s path to rare bile duct cancer research. Insight story from a NUTRIM PhD and chair of the NUTRIM PhD council.

Beating the odds: Julien Luyten’ s path to rare bile duct cancer research. Insight story from a NUTRIM PhD and chair of the NUTRIM PhD council.
In today’s business world, companies are under increasing pressure to embrace environmental and social responsibility, not just as an act of goodwill but as a fundamental business strategy. Yet, while corporate sustainability goals are plastered across glossy annual reports, what drives the leaders...
NWO grants 3 million euros to researchers, among them at Maastricht University, to ensure timely availability of innovative technologies for the Einstein Telescope.
Read the NUTRIM Special Holiday Edition Newsletter with the highlights of 2024
Maastricht University has secured over €400,000 in funding for the development of Coll-a-Gen, a synthetic, animal-free alternative to collagen. If successful, this project could herald a breakthrough in medical treatments, ranging from advanced wound healing to biocompatible implants.
On Tuesday, December 3rd, 2024, our Department of Translational Genomics hosted its very first TGX Conference Day! The event showcased the incredible research being conducted within our five key research lines.
The YOUTHreach study will evaluate and implement three very promising existing interventions to support young people with mental health challenges.
Maastricht University is partnering with Medlands Parkstad, an initiative that aims to foster innovation and nurture talent in the field of medical technology.
The government and several opposition parties have agreed on a budget for the Ministry of Education, Culture and Science. Higher education will be hit hard, although there are glimmers of hope. The total cuts to education and research have been reduced from €2 billion to just over €1.2 billion.